CD274 and neoplasm: We used the 111In-DOTA-anti-PD-L1 Ab conjugate kinetics at the different administered Ab doses to approximate the tumor to normal organ dose ratios for 225Ac-, 212Pb-, and 211At-labeled anti-PD-L1 Ab from organ time-integrated activity (TIA) calculations (Fig. 11).